Top Markets
Coin of the day
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Ранг среди акций #16315
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Цена акции
$0.94180721
Рыночная капитализация
$22.26M
Изменение (1 день)
0.38%
Изменение (1 год)
-14.35%
Страна
FR
Торговля Valbiotis SA (ALVAL)

Категория

История цены акций Valbiotis SA (ALVAL)
Наивысшая цена закрытия: $0.95 2026-07-01

Наименьшая цена закрытия: $11.52 2017-06-01
История цены акций Valbiotis SA с 2017 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -15.31%
2025 -7.34%
2024 -73.56%
2023 44.27%
2022 -51.96%
2021 6.16%
2020 207.03%
2019 -38.49%
2018 -47.84%
2017 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$49.07 -27.00%
DK
$476.31 2.61%
US
$656.12 19.74%
US
$277.09 39.62%
BE
$859.43 54.58%
NL